| Action Pharma A/S Patent applications |
| Patent application number | Title | Published |
|---|
| 20110082183 | PHENYL PYRROLE AMINOGUANIDINE DERIVATIVES - The present invention relates to phenyl pyrrole aminoguanidine derivatives of the general formula (I): (I) including tautomeric forms thereof, wherein n is 1, 2 or 3; or a pharmaceutically acceptable salt thereof. The present invention further relates to the use of such phenyl pyrrole aminoguanidine derivatives for the treatment of diseases associated with the melanocortin receptors or related systems, e.g. the melanocyte stimulating hormones. | 04-07-2011 |
| 20090069242 | THERAPEUTICALLY ACTIVE ALPHA MSH ANALOGUES - The invention describes peptide analogues of a-melanocyte-stimulating hormone (a-MSH), which posses an increased efficacy compared to the native α-MSH peptide. The α-MSH analogues exhibit increased anti-inflammatory effects and increased capability to prevent ischemic conditions compared to α-MSH. The invention further discloses use of the peptides for the manufacture of pharmaceutical compositions for the treatment or prophylaxis of a condition in the tissue of one or more organs of a mammal, and moreover pharmaceutical compositions. | 03-12-2009 |
| 20090018183 | N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands - The present invention provides novel compounds of the general Formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: | 01-15-2009 |
